ARTICLE | Clinical News
Intranasal interferon beta: Began Phase I trial
December 3, 2001 8:00 AM UTC
Nastech Pharmaceutical Co. Inc. (NSTK), Hauppauge, N.Y. Product: Intranasal interferon beta Business: Autoimmune/Inflammatory Therapeutic category: Immune modulation Target: NA Description: Nasally de...